Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites
Clinical trial NCT03665701 · COMPLETED
Trial details
- NCT number
- NCT03665701
- Sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2019-12-16
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.